Supported Symposia and Product Theaters

ISTH 2019 CONGRESS
  • About
    • Home
    • About the Congress
    • General Info
    • Leadership
    • Theme Leaders
    • Charity Run
    • Ancillary Meetings
    • PINOT Study
    • Contact
  • Program
    • Online Program
    • Plenary Sessions
    • Create an Itinerary
    • Pre-Congress Symposia
  • Register
    • Register Now
    • Registration FAQ
    • Awards & Grants
  • Abstracts
    • Download Abstracts
    • Abstract Submission
    • Presentation Guidelines
    • Poster Guidelines
    • Free Poster Printing
  • Hotel & Travel
    • Affordability
    • Hotel
    • Visiting Melbourne
    • Flight Bookings
    • Venue
  • Support/Exhibits
    • Supporters
    • Supported Symposia and Product Theaters
    • Destination Supporters
    • Exhibitors
    • Publishing Partners
    • Opportunities
  • Media
    • Media Information
    • Virtual Press Room

Plan to attend the following Supported Symposia and Product Theaters:

See the full Congress online program here.
Supported Symposia
  • Saturday, July 6, 11:30-12:45
  • Sunday, July 7, 7:00-7:45
  • ​Sunday, July 7, 13:15-14:30
  • ​Monday, July 8, 7:00-7:45
  • Monday July 8, 13:15-14:30
  • Tuesday, July 9 13:15-14:30
Product Theaters
  • Sunday, July 7 12:15-13:00
  • Monday, July 8 12:15-13:00
  • Tuesday, July 9 12:15-13:00
 
 

Saturday, July 6, 11:30-12:45 

**Lunch will be served as part of all Supported Symposia held on Saturday
Navigating the New World: Haemophilia in the 21st Century
Meeting Room 105
Supported by Sanofi Genzyme
Picture

Defining a New Paradigm for the Management of Acquired Thrombotic Thrombocytopenic Purpura
Meeting Room 106
Supported by Sanofi Genzyme
Picture

Inhibitors: Prevention and Evolving Treatment Paradigms
Meeting Room 109
Supported by GRIFOLS
Picture

A Decade of Innovation: from DOACs to Reversal Agents
Meeting Room 110
Supported by Boehringer Ingelheim
Picture

Transforming Research Into Clinical Reality: Takeda’s Gene Therapy Program in Hemophilia
Meeting Room 203/204
Supported by Takeda
Picture

​The Role of the Protein C System in a Rare Disorder and its Impact in Critical Care
Meeting Room 210/211
​Supported by Takeda
Picture

The Evolution of Turning Genes Into Medicine:  Leveraging Innovation To Create a Path Forward
Meeting Room 212/213
Supported by Spark Therapeutics, Inc.
Picture

Understanding the Outcomes of Anticoagulation: Insights From the GARFIELD Registries ​
Meeting room 219/220
​Supported by TRI
Picture
 

Sunday, July 7, 07:00-07:45

aTypical HUS: Finding a Needle in a Haystack
Meeting Room 219/220
Supported by Alexion Pharmaceuticals, Inc.
Picture
 

Sunday, July 7, 12:15-13:00

Current Treatment Challenges in ITP
Product Theater A
Supported by Amgen
Picture

Prophylaxis in Hemophilia A at Modest Doses Impacts the Clinical Outcomes
Product Theater B
Supported by GRIFOLS
Picture

​Update on HIT – from Pathophysiology to Treatment ​
Product Theater C
Supported by Aspen Pharma
Picture
Gene Therapy in Hemophila: An ISTH Education Initiative
Product Theater D
Supported by the ISTH
Picture
 

Sunday, July 7, 13:15-14:30

Anticoagulation for the Management of VTE in the NOAC era
Melbourne Room 1
Supported by Bristol-Myers Squibb/Pfizer
Picture

Introducing Esperoct®* (turoctocog alfa pegol), a New Extended Half-Life rFVIII — a Continuing Commitment to Patients with Haemophilia A
Melbourne Room 2
Supported by Novo Nordisk
​*This product is not approved in Australia
Picture

The Future of Haemophilia A: Discussing SubQ-8, a New Subcutaneous FVIII Development Based on Simoctocog Alfa 
Meeting Room 203/204
Supported by Octapharma
Picture

Taking Action in Hemophilia A: Transforming Patient Outcomes Through Innovation
Meeting Room 210/211
Supported by Takeda
Picture

Taking a Flexible Approach in Hemophilia B
Meeting Room 212/213
Supported by CSL Behring
Picture

Supporting Clinical Decision Making in Hemostasis by Innovative Diagnostic Solutions
Meeting Room 219/220
Supported by Roche
Picture
 

Monday, July 08, 07:00-07:45

VTE Prophylaxis and Improved Patient Outcomes in Orthopedic Surgery: How to Engage the Surgeon
Meeting Room 219/220
Supported by Cardinal Health
Picture
 

Monday, July 08, 12:15-13:15

Quantra, a Novel Viscoelastic Device for the Management of Acute Bleeding
Product Theater A
Supported by Stago
Picture

Ceprotin®: a Critical Treatment in the Management of SCPCD ​
Product Theater B
Supported by Takeda
Picture

The Chronic Risk of Arterial and Venous Thrombosis: Managing Prevention with NOACs
Product Theater C
Supported by Bayer AG
Picture

Think Again About vWD: Deliver Control To The Patient
Product Theater D
Supported by CSL Behring
Picture
 

Monday, July 08, 13:15-14:30

​Gene Transfer Gene Therapy: From Bench to Bedside
Melbourne Room 1
Supported by BioMarin Pharmaceutical Inc.
Picture

Conveniently Protecting What Matters: Nuwiq® (Simoctocog Alfa) in PUPs and Personalised Prophylaxis
Melbourne Room 2
Supported by Octapharma
Picture

​What Everyone Should Know About Elevating Standards of Care in Haemophilia ​
Meeting Room 203/204
Supported by Sanofi Genzyme and Sobi
Picture
Picture

Reversal of Specific Direct Novel Oral Anticoagulants in Patients Experiencing Life-Threatening Bleeds
Meeting Room 210/211
Supported by Portola Pharmaceuticals
Picture

Transformative Science in an Era of Comprehensive Care: From Lab to Life
Meeting Room 212/213
Supported by Pfizer
Picture

The Power of Design: Evolving the Standard of Care With Jivi®
Meeting Room 219/220
Supported by Bayer
Picture
 

Tuesday, July 9, 12:15-13:00

ADAMTS13 Diagnostics
Product Theater A
Supported by Technoclone
Picture

Optimizing Lab Efficiency in Coagulation
Product Theater B
Supported by Roche Diagnostics
Picture

Real-World Perspectives on Adopting Jivi® Into Your Practice
Product Theater C
Supported by Bayer
Picture
 

Tuesday, July 9, 13:15-14:30

Considering Emergent Approaches to Overcome Challenges for People With Haemophilia A Without FVIII Inhibitors
Melbourne Room 2
Supported by Roche
Picture

New Light Shed on VTE Prophylaxis in Medical Patients: The Current State of the art
Meeting Room 109/110
Supported by Sanofi
​This symposium will also be live-streamed. Please visit http://vteandmedpatients.isth2019.live.cyim.com for more information.

Picture

Managing Thrombotic Risk with Microvesicles: Ready for the Clinics?
Meeting Room 203/204
Supported by Stago
Picture

Harnessing Innovation to Transform Standards of Care in VWD and cTTP
Meeting Room 210/211
Supported by Takeda
Picture

Improving Outcomes in Hemophilia A
Meeting Room 212/213
Supported by CSL Behring​
Picture

Anticoagulation in Active Cancer Patients: How NOACs Changed Clinical Practice
Meeting Room 219/220
Supported by Bayer AG
Picture

See You in Melbourne!


About ISTH
​ISTH Meetings

Tel: +1 919 929 3807
​Fax: +1 919 929 3935
​Email us 

International Society on Thrombosis and Haemostasis (ISTH)
610 Jones Ferry Road, Suite 205, Carrboro, NC 27510, USA

  • About
    • Home
    • About the Congress
    • General Info
    • Leadership
    • Theme Leaders
    • Charity Run
    • Ancillary Meetings
    • PINOT Study
    • Contact
  • Program
    • Online Program
    • Plenary Sessions
    • Create an Itinerary
    • Pre-Congress Symposia
  • Register
    • Register Now
    • Registration FAQ
    • Awards & Grants
  • Abstracts
    • Download Abstracts
    • Abstract Submission
    • Presentation Guidelines
    • Poster Guidelines
    • Free Poster Printing
  • Hotel & Travel
    • Affordability
    • Hotel
    • Visiting Melbourne
    • Flight Bookings
    • Venue
  • Support/Exhibits
    • Supporters
    • Supported Symposia and Product Theaters
    • Destination Supporters
    • Exhibitors
    • Publishing Partners
    • Opportunities
  • Media
    • Media Information
    • Virtual Press Room